FierceBiotechOriginal article
{"a":[{"_":"Adagio Medical kicks off strategic review, trims more than half its staff","$":{"href":"/medtech/adagio-medical-implements-strategic-review-and-trims-more-half-its-staff","hreflang":"en"}}]}
Negative
AI Analysis
Summary
Adagio Medical has initiated a strategic review and is laying off more than half its workforce as the cryoablation device maker faces potential delisting from the Nasdaq exchange.
Outcome Details
Strategic review initiated; over 50% workforce reduction
Importance:6/10
Sentiment:
-0.80
restructuringlayoffsNasdaq delisting riskstrategic reviewcryoablation devices
Related Companies
Read the original article
Published by FierceBiotech on September 24, 2026 8:05 AM
